Brief: Hansa Biopharma Q1 Net Income SEK -218.6 Million
18/04/2024 06:00
Apr 18 (Reuters) - Hansa Biopharma Q1 revenue SEK 56 million. * Q1 adjusted EPS SEK -4.15 * Q1 cash & investments SEK 541.5 million
Recent news on Hansa Biopharma AB
See all newsBrief: Hansa Biopharma Q3 Rev Up At SEK 143 Mln
Sweden's Hansa Biopharma Q3 revenue surges on SERB license deal
Brief: Hansa Biopharma Q3 Net Income SEK -178.5 Million
Brief: Hansa Biopharma Announces Positive Idefirix Paes Results Presented In The High-Impact Clinical Trials Session At Asn Kidney Week
Brief: Hansa Biopharma Submits IND Application To FDA For HNSA-5487 In GBS